Abstract
Guidelines for management of patients with erectile dysfunction indicate that intraurethral and intracavernosal injection therapies represent the second-line treatment available. Efficacy of intracavernosal injections seems superior to that of the intraurethral delivery of drugs, and this may explain the current larger diffusion of the former modality. Safety of these two therapeutic options is well established; however, the attrition rate with these approaches is significant and most patients eventually drop out of treatment. Newer agents with better efficacy-safety profiles and using user-friendly devices for drug administration may potentially increase the long-term satisfaction rate achieved with these therapies. Topical therapy has the potential to become a first-line treatment for erectile dysfunction because it acts locally and is easy to use. At this time, however, the crossing of the barrier caused by the penile skin and tunica albuginea has limited the efficacy of the drugs used.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montorsi, F., Salonia, A., Zanoni, M. et al. Current status of local penile therapy. Int J Impot Res 14 (Suppl 1), S70–S81 (2002). https://doi.org/10.1038/sj.ijir.3900808
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900808
Keywords
This article is cited by
-
Nebenwirkungen der medikamentösen Behandlung der erektilen Dysfunktion
Der Urologe (2017)
-
What is the current role of intracavernosal injection in management of erectile dysfunction?
International Journal of Impotence Research (2016)
-
Repeated intracorporeal self-injection: effect on peak systolic velocity and cavernosal artery diameter
International Journal of Impotence Research (2007)
-
A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1
International Journal of Impotence Research (2005)
-
Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances
International Journal of Impotence Research (2004)